Skip to main content

Table 3 Anthropometric and antenatal characteristics of respondents (N = 356)

From: Maternal risk factors for low birthweight and macrosomia: a cross-sectional study in Northern Region, Ghana

Background characteristics

Frequency distribution

Bivariate analysis

Frequency

Proportion

Low birthweight

Macrosomia

Normal birthweight

p value†

n

%

n (%)

n (%)

n (%)

 

Body mass index (BMI)a

      

Underweight (< 18.5 kg/m2)

25

7.0

5 (6.3)

4 (12.9)

16 (6.5)

0.448

Normal BMI (≥ 18.5 to 24.9 kg/m2)

229

64.3

56 (70.9)

14 (58.1)

155 (63.0)

 

Overweight/Obese (≥ 25.0 kg/m2)

102

28.7

18 (22.8)

9 (29.0)

75 (30.5)

 

Mean = 23.37, sd = 3.40

      

Pre-pregnancy weighta

      

< 50 kg

42

11.8

11 (13.9)

5 (16.1)

26 (10.6)

0.533

≥ 50 kg

314

88.2

68 (86.1)

26 (83.9)

220 (89.4)

 

Height at first antenatal care (ANC) visits a

     

< 150 cm

13

3.7

3 (3.8)

0 (0.0)

10 (4.1)

0.522

≥ 150 cm

343

96.3

76 (96.2)

31 (100.0)

236 (95.9)

 

Gestational weight gaina

     

< 6 kg

94

26.4

31 (39.2)

3 (9.7)

60 (24.4)

0.003*

≥ 6 kg

262

73.6

48 (60.8)

28 (90.3)

186 (75.6)

 

Mean = 6.47, sd = 2.16

      

Childbirth height/lengthb

     

≤ 47.5 cm

72

20.2

32 (40.5)

2 (6.5)

38 (15.5)

 < 0.001*

> 47.5 cm

284

79.8

47 (59.5)

29 (93.5)

208 (84.5)

 

Mean = 47.35, sd = 2.71

      

Number of ANC visits

      

< 8 visits

191

53.7

63 (79.7)

5 (16.1)

123 (50.0)

 < 0.001*

≥ 8 visits

165

46.3

16 (20.3)

26 (83.9)

123 (50.0)

 

Place of ANC visits

      

Hospital

175

49.2

40 (50.6)

15 (48.4)

120 (48.8)

0.956

Health centre

181

50.8

39 (49.4)

16 (51.6)

126 (51.2)

 

Family planning (FP) use before last pregnancy

    

No FP use

232

65.2

50 (63.3)

20 (64.5)

162 (65.8)

0.914

FP use

124

34.8

29 (36.7)

11 (35.5)

84 (34.2)

 

Insecticide-treated nets (ITNs) use

      

No ITNs use

138

38.8

46 (58.2)

10 (32.3)

82 (33.3)

 < 0.001*

ITNs use

218

61.2

33 (41.8)

21. (67.1)

164 (66.7)

 

ITNs frequency of use (n = 218)

     

Every night

179

82.1

25 (75.8)

17 (80.9)

137 (83.5)

0.562

Sometimes

39

17.9

8 (24.2)

4 (19.1)

27 (16.5)

 

Number of sulphadoxine-pyrimethamine (SP) intake

    

None

18

5.1

8 (10.1)

1 (3.2)

9 (3.7)

0.002*

1–3 doses

141

39.6

40 (50.6)

6 (19.4)

95 (38.6)

 

> 3 doses

197

55.3

31 (39.2)

24 (77.4)

142 (57.7)

 

Dewormer (anthelminthics) intake

     

No intake

218

61.2

46 (58.2)

16 (51.6)

156 (63.4)

0.367

Intake

138

38.8

33 (41.8)

15 (48.4)

90 (36.6)

 

Iron/folic acid (IFA) intake

      

No IFA intake

13

3.7

4 (5.1)

0 (0.0)

9 (3.7)

0.444

IFA intake

343

96.3

75 (94.9)

31 (100.0)

237 (96.3)

 

Tetanus diphtheria (TD) immunization

      

Not immunized

26

7.3

7 (8.9)

3 (9.7)

16 (6.5)

0.679

Immunized

330

92.7

72 (91.1)

28 (90.3)

230 (93.5)

 

Reception of nutrition education

     

Not received

47

13.2

11 (13.9)

7 (22.6)

29 (11.8)

0.241

Received

309

86.8

68 (86.1)

24 (77.4)

217 (88.2)

 
  1. *p value < 0.05
  2. †Chi-square test/Fisher’s exact test
  3. aCategorization based on previous studies [31, 33, 38]
  4. bCategorization based on previous studies [30]